Richard Woodman, MD Chief Clinical Officer, Oncology Business Group at Eisai, Inc.. In this video, he speaks about the ASCO…
Browsing: Uterine
Endometrial Cancer
Richard Woodman, MD Chief Clinical Officer, Oncology Business Group at Eisai, Inc.. In this video, he speaks about the ASCO…
Alessandro Santin, MD of Byondis shares his final thoughts on the study: Byondis Initiates Phase II Study of Antibody-Drug Conjugate…
Alessandro Santin, MD of Byondis talks about what are the next steps for the study: Byondis Initiates Phase II Study…
Alessandro Santin, MD of Byondis speaks about will this affect clinicians today on the study: Byondis Initiates Phase II Study…
Alessandro Santin, MD of Byondis answers common questions on the study: Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab…
Alessandro Santin, MD of Byondis talks about the study: Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced…
With the involvement of so many genetic and molecular alterations in cancer, it is nearly impossible to know what pathway…
The recent Phase II VinCap trial (NCT02057913) shows promising results for vinflunine as a chemotherapy for locally-advanced and metastatic carcinoma…